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Materials capable of releasing reactive oxygen species (ROS) can display antibacterial and anticancer
activity, and may also have anti-oxidant capacity if they suppress intracellular ROS (e.g. nitric oxide, NO)
resulting in anti-inflammatory activity. Herein we report silver phosphate (Ag3PO4)/polyindole (Pln)
nanocomposites which display antibacterial, anticancer and anti-inflammatory activity, and have
therefore potential for a variety of biomedical applications.Introduction
Microbial infections are a globally important issue due to the
evolution of drug resistant microbes (particularly Enterococcus
faecium, S. aureus, Klebsiella pneumoniae, Acinetobacter bau-
mannii, Pseudomonas aeruginosa and Enterobacter species)
which are responsible for hospital infections and represent
a signicant burden for healthcare systems.1–3 Nanomaterials
have gained increasing attention as potential alternatives to
antibiotics3 due to the ease with which we can tailor their
properties (e.g. particle size, morphology and crystal defects).4–6
Understanding the mechanism of the antibacterial activity of
these nanomaterials is important to control their dosing in vivo
and any potential environmental impact.7 The ability of nano-
materials to generate reactive oxygen species (ROS) including
superoxide anions (O2c
),8 hydroxyl radicals ($OH),8 singlet
oxygen (1O2)9,10 and secondary oxygen centered species such as
hydrogen peroxide (H2O2) which is developed during the
disproportionation of O2c
 which further transforms into $OH
and 1O2,9,10 is of particular interest in regards to toxicity due to
the ability of such oxygen centered reactive species to oxidize
various cellular constituents.9,11,12 H2O2 can exert oxidativeanotechnology, Jadavpur University,
yahoo.co.in
nication Engineering, C V Raman Global
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073stress on biological systems9 by generating ROS intracellularly.13
Intracellular ROS can be endogenous (generated naturally by
metabolic processes) or exogenous (generated by other species,
e.g. nanomaterials).14 Various nanomaterials display antibacte-
rial activity: e.g. ZnO,15,16 TiO2,17,18 MgO,6 ZnO/TiO2 nano-
hybrids,19 ZnO/ZnFe2O4,20 CuO,21 Ag3PO4 (ref. 22) etc. In vitro
studies detecting ROS derivation from nanomaterials enables
the establishment of the underlying mechanism of antibacterial
activity to some extent, as the production of different ROS (O2c
,
$OH and 1O2) are dependent on the size,23–25 shape,24,26,27 and
heterostructures of the nanomaterials,6 but there remains some
ambiguity in their mechanism of function.
In addition to ROS-mediated antibacterial activity, non ROS-
mediated antibacterial activity caused by the dissolution of
cations,1,23,24,26 internalization of nanostructures,24 cell
membrane disruption,28 retardation of enzyme activity3,7 and
DNA synthesis,29 interruption of energy transduction,3,7 etc. are
all able to contribute to antibacterial activity. Studies in the
scientic literature demonstrate ROS mediated antibacterial
activity of different metal oxides for typical durations of 24 h
(ref. 6 and 16) to 48 h.30 Studies of “prolonged exposure” re-
ported either antibacterial activity aer long term storage of the
nanomaterials repeated exposures31,32 and the exposure of
bacteria to such nanomaterials for durations longer than 24 h
with subsequent monitoring of bacterial growth are relatively
uncommon.31,33
Our understanding of the underlying mechanism of the
existing long term antibacterial activity of nanoparticles in vitro/
vivo is still relatively nascent.34 The simultaneous existence of
ROS and non ROS mediated long term antibacterial activity in
nanomaterials is therefore an important area of research.
Nanomaterials that produce ROS0 can be used to treat cancer
cells,35,36 with cell apoptosis achieved by nanomaterial induced
ROS generation.14,37
Antibacterial therapy lacks anti-inammation, as the ROS
mediated antibacterial operation is likely to be pro-inammatory.This journal is © The Royal Society of Chemistry 2020
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
M
ar
ch
 2
02
0.
 D
ow
nl
oa
de
d 
on
 4
/2
8/
20
20
 4
:0
1:
49
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineInvestigating the anti-oxidant properties of such nanomaterials
towards macrophages is of interest, because macrophage tar-
geting may be an effective strategy to deliver anti-inammatory
drugs to sites of inammation.38 Inammation (a localized
swelling, pain, redness due to some injury or infection) is
promoted by several mechanisms including ROS generation in
macrophages.39 Studies on nanoparticle induced anti-
inammatory activity in macrophages suggest inammation is
activated by extracellular matrix protein, lipopolysaccharides
(LPS) and cytokines.38 The size of nanoparticles facilitates their
uptake by macrophages.38 In vitro studies on the anti-
inammatory activity of RAW 264.7 macrophages by nano-
particles (e.g. PLA-PEG, Prussian blue nanoparticles),40,41 and in
vivo studies using biogenic Ag nanoparticles (NPs) demonstrated
that the NPs exhibited simultaneous antimicrobial and anti-
inammation activity,42 via various anti-inammatory path-
ways.43 Despite the literature on metal oxide nanoparticle
induced anti-inammatory activity38,39 there is little literature on
the anti-inammatory effects of nanoparticles in the light/dark.
Materials with simultaneous antibacterial and anti-
inammation activity have potential for a variety of biomedical
applications.
Polymers displaying antimicrobial properties are the subject
of signicant attention for their potential technical andmedical
applications.44–49 Polyindoles have excellent thermal stabilities
(important for sterilization, e.g. in an autoclave) and redox
activities and therefore have potential for application as anti-
bacterial materials.48–50 Ag3PO4 displays visible light induced
antibacterial activity,51 albeit concomitant with photo-
degration.52 The valence band edge potential of Ag3PO4 (EVB ¼
2.66 eV) is greater than EH of $OH/H2O (2.2 eV) which makes it
a potent source of $OH radicals, which has been shown to result
in antibacterial activity.16 The composites reported here also
show radical induced antibacterial activity. Pln was chosen to
stabilise the nanocomposite as Ag3PO4 is structurally unstable
when it is dissolved in water.53 Pln is a chemically and thermally
stable polymer48 which can inhibit Ag3PO4 decomposition,
moreover, its valence band edge potential (EVB ¼ 3.45 eV) can
induce elevated $OH which inhibits bacterial population.
Herein we report the results of our studies on the structure
and properties of Ag3PO4/polyindole composites and their
antibacterial activity towards Gram positive S. aureus and Gram
negative E. coli at different points in time (1, 2, 5 and 7 days in
culture). The antibiolm activity of the nanocomposites was
explored in the dark. The intra-cellular ROS generation and
bacterial cell membrane disintegration were monitored using
20,70-dichlorouorescein diacetate (DCFH-DA) and propidium
iodide (PI) dye respectively. Furthermore, we explored the
application of the nanocomposites in MCF-7 breast cancer cells
to understand their potential for use in ROS mediated cancer
therapy. Finally, we examined the anti-inammatory activity of
the nanocomposites towards human monocyte THP-1 derived
macrophages to understand the radical scavenging behaviour.
The broad spectrum of interesting properties displayed by such
nanocomposites offer them opportunities for a multitude of
biomedical applications.This journal is © The Royal Society of Chemistry 2020Experimental
Materials and methods
Silver nitrate (AgNO3), sodium chloride (NaCl), potassium
chloride (KCl), potassium dihydrogen phosphate (KH2PO4) were
supplied by Merck, India. Indole (C7H8N, 99%), ammonium
persulphate ((NH4)2$S2O8, 98%), terephthalic acid (TA, C8H6O4,
98%), 20,70-dichlorouorescin diacetate (DCFH-DA, 97%), thia-
zol blue tetrazolium bromide (MTT) were supplied by Sigma
Aldrich. Nitroblue tetrazolium chloride (NBT), propidium
iodide (PI), nutrient broth (NB), nutrient agar (NA), crystal violet
(CV), Furfuryl alcohol (FFA), Dulbecco's modied eagle's
medium (DMEM), transparent 96 well-plates were supplied by
Himedia, India. Black 96 well plates were obtained from
Eppendorf AG, Germany. Fetal bovine serum (FBS) was
procured fromGibco, L-Glutamine–Penicillin–Streptomycin was
purchased from Central Drug House Fine Chemicals, Delhi,
India. Ethanol was supplied by Merck, Germany. 0.45 mm lter
paper was supplied by Whatman. Roswell Park Memorial
Institute (RPMI) 1640 was obtained from Lonza Bio-
Whittaker™. The THP-1 peripheral blood acute leukaemia cell
line was purchased at passage 2 from Sigma-Aldrich (88081201,
USA). 1,1-Diphenyl-2-picrylhydrazyl radical (DPPH), HEPES,
sodium pyruvate, phorbol 12-myristate 12-acetate (PMA), and
lipopolysaccharide (LPS) were supplied by Sigma Aldrich (Gil-
lingham, UK). IFN-g and recombinant human macrophage
colony stimulating factor (M-CSF) were purchased from Pepro-
Tech, USA. MCF-7 breast cancer cell lines were obtained from
NCCS, Pune, India. Both Gram-positive S. aureus (ATCC 29737)
and Gram-negative E. coli (ATCC K88) were purchased from
ATCC. Unless otherwise noted, all reagents were used without
any further purication.Synthesis of Ag3PO4
Ag3PO4 nanocrystals were prepared according to the literature
with some minor modications.53 Briey, AgNO3 (0.4 g) was
added to distilled (DI) water (20 mL) and stirred for 15 min aer
which an aqueous solution of Na2HPO4 (0.284 g in 20 mL DI
water) was added dropwise and the mixture was stirred for 5 h.
The yellow precipitate was isolated by centrifugation and
washing repeatedly with DI water and ethanol (until the liquid
was clear and colourless) aer which it was dried under vacuum
at 55 C for 24 h to obtain Ag3PO4 nanocrystals.Synthesis of polyindole (Pln)
Polyindole was synthesized by ammonium persulfate initiated
polymerisation of indole using a process reported in the liter-
ature.54 The as synthesized polyindole is hereaer referred to as
Pln0.Preparation of Ag3PO4/polyindole composites
Ag3PO4/polyindole composites were prepared by in situ growth
of Ag3PO4 nanocrystals inside a matrix of polyindole by adap-
tation of the literature.55 As synthesized Pln0 (0.1 g) was
dispersed in DI water (25 mL) and sonicated for 5 min. A certainRSC Adv., 2020, 10, 11060–11073 | 11061
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View Article Onlineamount of AgNO3, which was decided by the weight percentage
of PIn in the PIn/Ag3PO4 composite, was added into this mixture
and the liquid mixture was stirred for 1 h. A certain amount of
Na2HPO4, which is equal to 33.33% (in mole percentage) of the
added AgNO3 in the liquid mixture, was dissolved in 25 mL
deionized water. The prepared Na2HPO4 solution was then
slowly added dropwise into the stirred mixture of PIn and
AgNO3. The suspension was stirred for 5 h. The mixture was
centrifuged and washed with anhydrous ethanol and DI water
repeatedly until the liquid was clear and colourless, aer which
the composites were dried under vacuum at 55 C for 24 h. The
amount of AgNO3 present in the composites was quantied
using a high precision balance and recording the mass of
starting polyindole (0.1 g) and mass of the composite aer
washing and drying. Ag3PO4/Pln composites with mass ratios of
4 : 1, 2 : 1, and 1 : 1 (w/w) were designated as Pln1, Pln2 and
Pln3, respectively.
Characterization
The crystallinity and phase of the samples were characterized by
X-ray diffraction (XRD) (Ultima-III, Rigaku, Japan). The size and
morphology of the samples were characterized by scanning
electron microscopy (SEM) and transmission electron micros-
copy (TEM). SEM images were obtained using a JEOL JSM 7800F
scanning electron microscope (JEOL, Welwyn Garden City,
UK).For qualitative EDX analysis, the samples were sputter
coated with a layer of gold (60 s, 20 mA, 8  102 mBar,
ca. 5 nm) using a Quorum Q150RES sputter coater (Quorum
Technologies Ltd) and then investigated using a eld-emission
SEM JEOL JSM 7800F with an energy dispersive X-ray spectros-
copy (EDX) system (X-Max50, Oxford Instruments, Abingdon,
UK) at 10 mm working distance and 10 kV voltage mounted on
a brass JEOL holder with 25 mm carbon tabs (G3348N, Agar
Scientic, Stansted, UK). Three measurements were performed
per sample and average results are presented. TEM images were
obtained for the samples collected onto 400 mesh formvar
carbon grids (Agar Scientic, UK) in a JEOL 10–10 TEM at 80 kV
images acquired with an AMT NanoSprint500 (Deben, UK).
Fourier transform infrared (FTIR) spectra of the samples were
obtained using an IR Prestige (Shimadzu, Japan) in absorbance
mode. Diffused reectance spectroscopy was conducted using
a UV-Vis spectrophotometer (Shimadzu, Japan), and z potential
wasmeasured using a Zetasizer NS Nano, zeta analyser (Malvern
Panalytical Ltd, Malvern, UK).
Antibacterial activity measurement
The antibacterial activity of Ag3PO4/Pln nanocomposites was
evaluated by minimum inhibitory concentration (MIC) tests
and turbidity methods against Gram-positive bacteria S. aureus
and Gram-negative bacteria E. coli. MIC evaluation was carried
out by agar dilution method.56 Specically the nanocomposites
were dissolved in DMSO (2%) and sterile water to make the nal
concentration of 2000 mg mL1 which was further diluted to 0.5,
1, 5, 10, 20, 40, 100, 200, 400, 600, 800, 1000 mg mL1. Each
inoculum (2  106 CFU mL1) was spotted in agar plates con-
taining those concentrations and incubated at 37 C for 24 h.11062 | RSC Adv., 2020, 10, 11060–11073Minimum concentration of the drug that inhibits bacterial
growth was recorded as MIC. For turbidity measurements 200
mL of the nanocomposite solutions were added to 1 mL of fresh
inoculums (1.5  108 CFU mL1) in 2 mL Eppendorf tubes
and incubated at 37 C for 24 h in an orbital shaker (150 rpm).
Bacteria without nanocomposites were used as control. The
absorbance of bacterial suspension was recorded using UV-Vis
spectrophotometer (JASCO V650) at 600 nm. The antibacterial
potency was expressed as change in absorbance at 600 nm.57
% Inhibition ¼ ODcontrol ODsample
ODcontrol
 100 (1)
The antibacterial activity tests were performed in triplicate.Anti-biolm activity measurement
Biolm inhibition of S. aureus and E. coli was quantied by
a colorimetric detection process.6,16,58 Specically, fresh inocu-
lums (1  106 CFU mL1, 200 mL) was pipette out white 96 well-
plate onto which the nanocomposite solutions (1g L1) were
added and incubated at 37 C for 4 days. Control wells were
marked without the nanomaterials. Each incubated well was
rinsed thrice with sterile distilled water to remove any free
bacteria. CV (10% (v/v), 400 mL) was pipetted out of each well
and le for 1 h to stain the biolm followed by washing with
sterile distilled water. Quantication of biolm was assessed by
eluting CV with 95% ethanol (400 mL) for 10 min. Finally, the
mixture (200 mL) was pipetted out into another transparent 96-
well plate and the absorbance was recorded at 570 nm by UV-Vis
spectrophotometer (SpectraMax M5, Molecular Devices). Bio-
lm inhibition was expressed as change in absorbance at
570 nm and calculated as:
% Inhibition ¼ Acontrol  Asample
Acontrol
 100 (2)
In vitro reactive oxygen species detection
The in vitro study of reactive oxygen species (ROS) generation
from Ag3PO4/Pln nanocomposites was conducted by measuring
the generation of superoxide anion (O2c
) and hydroxyl radical
($OH) as previously reported by our group.57 Typically for O2c

generation, each sample (1000 mg mL1) was added into NBT (1
mM) solution with vigorous stirring in the dark for 24 h. The
reaction product was then subjected to centrifugation
(5000 rpm, 10min) and ltration aer which the aliquots (3 mL)
were collected and the absorbance was recorded with an UV-Vis
spectrophotometer (JASCO V650) at 259 nm using quartz
cuvettes with 1 cm path length.
For $OH generation, TA (2 mM) was added to an aqueous
suspension of each of the nanocomposite with their bare
counterparts (1000 mg mL1) with vigorous stirring in the dark
for 24 h. The reaction product (5 mL) was subjected to centri-
fugation (5000 rpm, 10 min) and successive ltration (What-
man, 0.45 mm) and 200 mL of the supernatant was transferred
into black 96-well plates. The uorescence intensity (lex 312 nm/
lem 430 nm) was measured with a uorescence plate reader
(SpectraMax M5, Molecular devices).This journal is © The Royal Society of Chemistry 2020
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
M
ar
ch
 2
02
0.
 D
ow
nl
oa
de
d 
on
 4
/2
8/
20
20
 4
:0
1:
49
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineFor 1O2 generation, FFA (0.85 mM) was added to an aqueous
suspension of each of the nanocomposite with their bare
counterparts (1000 mg mL1) with vigorous stirring in the dark
for 24 h. The reaction product (5 mL) was subjected to centri-
fugation (5000 rpm, 10 min) and successive ltration (What-
man, 0.45 mm). The aliquots (3 mL) were collected and the
absorbance was recorded with a UV-Vis spectrophotometer
(JASCO V650) at 217 nm using quartz cuvettes with 1 cm path
length.
Intra-cellular ROS detection
Intra-cellular ROS detection for Ag3PO4/Pln nanocomposite was
carried out by minor adaptation of the literature.59 In a typical
process, Gram positive bacteria S. aureus and E. coli were freshly
grown up to log phase (OD600 ¼ 0.2 corresponding to 108 CFU
mL1) in Nutrient broth (NB). The grown bacteria were treated
with 1g L1 of Ag3PO4, Pln0, Pln1, Pln2 and Pln3 for 1 h,
centrifuged at 8000 rpm for 5 min and suspended in saline
(0.8 g L1 NaCl, 0.2g L1 KCl). Bacteria without nanomaterials
were used as controls. 2,7-Dichlorodihydrouorescein diacetate
(DCFH-DA), a uorescence probe was added to each of speci-
mens and incubated for 3 h at ambient temperature in the dark.
The uorescence of each sample was then measured by uo-
rescence plate reader (Spectra Max M5, Molecular device) with
excitation and emission wavelengths of 485 nm and 530 nm
respectively.
Membrane integrity test
Permeability of the inner bacterial membrane was studied with
a membrane-impermeable uorescent dye, PI (Propidium
iodide).60 Freshly prepared S. aureus and E. coli were diluted to
OD600 ¼ 0.05, centrifuged at 8000 rpm for 5 min and suspended
in PBS buffer. A stock solution of PI (3 mM in sterilised water)
was diluted 103-fold of which 2 mL was added to bacterial
suspension. 1 g mL1 of Ag3PO4, Pln0, Pln1, Pln2 and Pln3 were
added to the PI containing bacterial suspension and kept for
15 min in 96 well plate. The uorescence intensity was
measured with a uorescence plate reader (SpectraMax M5,
Molecular Device) at 25 C with excitation and emission wave-
lengths of 540 and 610 nm, respectively.
Cytotoxicity determination assay
To evaluate the cytotoxicity of the Ag3PO4/Pln nano-
composites against different mammalian cells. The cyto-
toxicity of the materials was evaluated using a MTT assay
against Peripheral Blood Mononuclear cells (PBMC) and
MCF-7 breast cancer cells to determine cell metabolic
activity.59,61 Aer attainment of 70% conuence the cells
were seeded in 96 well plates at a density of 0.3  104 cells
per well aer which they were treated with materials at
different concentrations and incubated at 37 C with 5%
CO2 atmosphere for 24 h. Aer 24 h of incubation, MTT at
5 mg mL1 is transferred to each well and the whole system
is incubated for 3 h at 37 C. The incubation is terminated by
recording the absorbance of cells at 590 nm using a UV-Vis
Spectrophotometer (Version 2.00, Agilent TechnologiesThis journal is © The Royal Society of Chemistry 2020Cary 60). All experiments were carried out in triplicate and
the results are obtained reported as the mean  standard
deviation.Cell culture
PBMC isolation and culture. A density gradient separation
method was employed to isolate the human PBMCs. Ethical
permission for blood collection was granted by the Institutional
Bio-Ethics committee, Jadavpur University (letter dated
24.03.2017 against application dated 21st December, 2016).
Typically, 3 mL of the human blood was mixed with anticoag-
ulant agent EDTA aer collected from a healthy donor with his/
her consent. The as collected blood was thereaer diluted to
1 : 3 ratio with chilled saline (0.9%) out of which 7.5 mL of the
diluted blood was added to 2.5 mL of Lymphoprep (Fresenius
Kabi Norge AS) in order to develop a density gradient solution.
Subsequently the blood was centrifuged at 5000 rpm for 30 min
in order to lter the mononuclear cells that appear as white
rings. The cells are subsequently washed with PBS and serum
free RPMI-1640 medium and suspended in RPMI 1640 medium
supplemented with 10% Fetal Bovine Serum (FBS) and 1%
penicillin–streptomycin. Finally, the cells were maintained in
a humidied incubator with 5% CO2 at 37 C.
MCF-7 breast cancer cell culture. MCF-7 breast cancer cell
lines were freshly prepared as per standard animal cell culture
laboratory protocol.59 Typically the cells were grown in DMEM
supplemented with 10% FBS, 100 U mL1 penicillin and 100 mg
mL1 streptomycin. The cells were thereaer maintained at
37 C in a humidied incubator with 5% CO2. When 70%
conuence is arrived the cells were washed with DMEM twice
and incubated with nanomaterial in a 96 well plate.
In vitro anti-oxidation measurement. The anti-oxidation
activity of nanomaterials was determined by the free radical
scavenging capacity of the nanomaterials. The nanocomposites
were prepared at a concentration of 1 mgmL1 inmethanol and
homogenized in an ultrasonic bath (FB11201, Fisherbrand) for
20 minutes. The DPPH free radical was made at 0.1 mM in
methanol, and mixed with the nanocomposite suspension in
a ratio of 300 mL : 100 mL. The mixed solution was then
homogenized by vortex for 20 seconds and cultured at room
temperature for 30 minutes. Solutions were ltered aer incu-
bation and read by a plate reader (BioTek) at 517 nm, with
methanol as control.
In vitro anti-inammation study. THP-1 cells were cultured
in RPMI 1640 supplement with 10% FBS, 1% penicillin–strep-
tomycin, 10mMHEPES and 1mM sodium pyruvate. THP-1 cells
were seeded in Corning® 96 well plates at a density of 2  104
cells per well with the inducing media that consisted of 100 ng
mL1 PMA and 100 ng mL1 of M-CSF, and cultured for 48 h.
Aer that, the THP-1 derived macrophages were refreshed with
fresh culture media with 1 mg mL1 LPS, IFN-g and each type of
particles at a ratio of 50 particles per cell. The cell culture media
was collected aer 18 h culture in the dark, and mixed with the
Griess reagent solution (1% sulfanilamide, and 0.1% naphtha-
lene diamine dihydrochloride in 2.5% phosphoric acid) at
a ratio of 50 mL : 50 mL. The mixture was incubated at roomRSC Adv., 2020, 10, 11060–11073 | 11063
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View Article Onlinetemperature for 10 minutes and read by a plate reader (BioTek)
at 540 nm.Results and discussion
Nanocomposite characterization
Fig. S1A† depicts the XRD pattern of the investigated samples.
Fieen diffraction peaks corresponding to 2q ¼ 20.85, 29.70,
33.30, 36.55, 42.50, 47.79, 52.7, 55.00, 57.29, 61.64,
69.95, 71.90, 73.85, 87.25, 89.15 were identied for all the
samples. They were readily indexed as (110), (200), (210), (211),
(220), (310), (222), (320), (321), (400), (420), (421), (332), (520),
(521) planes of body centred cubic structures of Ag3PO4 (JCPDS
le no. PDF # 06-0505). The absence of any other peak validated
the phase purity of the synthesized composites.52 The average
crystallite size was calculated from the Debye–Scherrer relation:
D ¼ 0:9l
b cos q
(3)
where D is the crystallite size, l ¼ 1.5406 A˚, and q and b repre-
sent the Bragg's diffraction angle and FWHM respectively. The
broad diffraction pattern around 2q¼ 20.3–26.9 was attributed
to formation of pure polyindole (Pln0).48 It is interesting to note
that the pattern did not vary in peaks in case of Pln1, Pln2 and
Pln3 which indicated unaffected crystal structure of Ag3PO4
particles inside the matrix of Pln or on its surface. In these
samples, no characteristic peaks of Pln were detected implying
coating of Ag3PO4 by amorphous Pln.48 The formation of
Ag3PO4/Pln composite was further conrmed by FTIR spectra
(Fig. S1B†). An intense peak at 744 cm1 related to C–H of Pln
was diminished from Pln3 to Pln1 (ref. 48) (Fig. S1B–D†). The
strong peak at 1102 cm1 corresponding to the C–N of Pln0 (ref.
48) also decreased in intensity from Pln3 to Pln1. Similarly the
C–N and C]C (stretching) peaks of Pln0 observed at 1456 cm1
and 1613 cm1, respectively,48 diminished from Pln to Pln3 to
Pln1. The presence of Ag3PO4 in all composites was further
affirmed from presence of characteristic peaks at 561 cm1 and
1011 cm1 which corresponded to asymmetric bending and
asymmetric stretching of P–O bonds of pristine Ag3PO4.62
Interestingly the intensity of these peaks was lower in Pln3 and
Pln2 as compared to Pln1 implying that decreasing Ag3PO4
proportion from Pln1 to Pln3. Peaks at 1388 cm1, 1679 cm1
and 3120 cm1 of pristine Ag3PO4 corresponded to antisym-
metric stretching mode of the PO4
3 group, and the bending
vibration of H–O–H and stretching vibration of O–H group due
to water molecules adsorbed on the surface respectively.62 These
peaks almost disappear and blue shied in Pln2 and Pln3
implying some of the Ag3PO4 was buried inside the Pln
matrix.63
Fig. S2† depicts characteristic SEM images of pristine
Ag3PO4, Pln0 and their composites. Pre Ag3PO4 particles were
observed to agglomerate; Pln0 particles were mostly spherical,
whereas the composites appeared to be spherical particles with
Ag3PO4 particles visible on the surfaces. EDX data supported the
proposed elemental compositions (i.e. Ag, P and O for the
Ag3PO4, C, N, O for the polyindole Pin0, and a mixture of these
for the composites). The TEM results (Fig. S3A–F†) correlated11064 | RSC Adv., 2020, 10, 11060–11073with the FESEM results for the samples of Pln0, Pln1, Pln2 and
Pln3; showing agglomerates of mostly spherical and oblate
shaped particles with some angular particles visible. When
examined under extreme magnication the TEM images
suggest that the Ag3PO4 material was heterogeneous with
approximately 10 nm sized internal inclusions visible
(Fig. S3B†). Importantly, for the composites, the TEM images
show there to be Ag3PO4, embedded in the PIn particles (i.e. not
only on the surface).
The band gap energy (Eg) of pure Ag3PO4, Pln0 and their
composites were characterized by diffused reectance spec-
troscopy (Fig. S4†) and the respective values were 2.39, 2.46,
2.36, 2.42 and 2.33 eV as estimated by the Kubelka–Munk (K–M)
function.62 The band gap values of pure Ag3PO4 and Pln could
facilitate generation of $OH but no O2c
 due to the band edge
energy. The band edge energy was calculated using the elec-
tronegativity and Eg:56,64
EVB ¼ c Ee þ 1
2
Eg (4)
ECB ¼ EVB  Eg (5)
where EVB and ECB are the conduction and valence band edge
potential, c is the Mulliken electronegativity,65 Ee is the free
electron energy on the hydrogen scale (4.5 eV)66 and Eg is the
band gap of material.
According to the above-mentioned relation the EVB and ECB
of pure Ag3PO4 (c ¼ 5.96 eV) and Pln0 (c ¼ 6.717 eV) were 2.66,
0.27 eV and 3.45, 0.99 eV in NHE scale respectively. The redox
potential (EH) of O2c
/O2 and $OH/H2O were 0.2 eV and 2.2 eV
respectively67 thus Ag3PO4 and Pln0 both could not be capable
to generate O2c
 in conduction band (ECB > EH O2c
/O2) but $OH
can be yielded from their valence band (EVB > EH $OH/H2O)
accordingly. Additionally EH of
1O2/O2 is 1.8 eV in NHE scale67
thus Ag3PO4 and Pln0 can yield
1O2 as their EVB were greater
than the prescribed value.Study of long term antibacterial activity
Metal oxide nanoparticles and their composites were estab-
lished as potent antibacterial agents8,16 due to defect induced
ROS generation and their respective oxidative stress but their
antibacterial activity is observed to deteriorate aer prolonged
exposure.54 Interestingly in this present work we have demon-
strated antibacterial activity of Ag3PO4/polyindole composites
aer prolonged exposure for 1–7 days. For this purpose Ag3PO4/
polyindole nanocomposite were exposed to two of the most
common pathogenic bacteria including Gram-positive S. aureus
and Gram-negative E. coli. Initially we have investigated MIC of
each type of nanocomposite (shown in Table 1).
The MIC values of the Ag3PO4/polyindole composite was
found to be comparable with that of other metal oxide nano-
particles.9,68,69 Interestingly, the Ag3PO4/polyindole nano-
composites extraordinarily exhibit growth inhibition property
against both bacteria whereas Pln0 does not exhibit any anti-
bacterial activity at this concentration range. Observations
reveal that Pln1, Pln2 and Pln3 were more sensitive to bothThis journal is © The Royal Society of Chemistry 2020
Table 1 Minimum inhibitory concentration (MIC) value of pristine
Ag3PO4, Pln0, Pln1, Pln2 and Pln3
Sample
MIC (mg mL1)
E. coli S. aureus
Ag3PO4 5.0 20.0
Pln0 Not found Not found
Pln1 0.5 5.0
Pln2 0.5 5.0
Pln3 0.5 5.0
Fig. 1 (A and B) Growth kinetics of E. coli and S. aureus in the presence
of pure Ag3PO4, Pln0 and Ag3PO4/polyindole composites in the dark
respectively. (C and D) % inhibition efficiency of E. coli and S. aureus
after incubation with pure Ag3PO4, Pln0 and Ag3PO4/polyindole
nanocomposites for different time periods respectively. CNTRL is
untreated bacteria as a control.
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View Article Onlinebacteria as compared to bare Ag3PO4 implying a synergistic
effect of the nanocomposites. Additionally the sensitivity of all
samples was more to E. coli than S. aureus. This behaviour
suggested a physiological difference between these two bacte-
rial strains. S. aureus has a thicker peptidoglycan layer at its cell
wall as compared to E. coli so it may be easier for the nano-
composite to diffuse into the cell wall of E. coli than S. aureus
but such an event can only be possible if there is close contact
between nanomaterial and bacteria. This proximity was
a resultant phenomenon due to electrostatic attraction between
nanomaterials and bacteria due to the surface charge of both
entities. Fig. S5† depicts the zeta potential of Ag3PO4/Pln
nanocomposite along with their bare forms. From Fig. S5† it
was observed that all nanomaterials had a highly negative
surface charge especially Pln3 which renders the close proximity
of the nanomaterials and bacteria less likely as the surface
charge of E. coli and S. aureus were 47 mV and 38 mV
respectively.70 The data presented in Table 1 showing the
excellent bacterial sensitivity of the nanocomposites suggested
other phenomenological events inuence theMIC. Based on the
MIC result and our motivation to study the prolonged anti-
bacterial activity measurements we have investigated bacterial
interactions with nanocomposites aer 24 h, 48 h, 120 h and
168 h (7 days) using a turbidity method16 produced a more
accurate result against S. aureus and E. coli. (shown in Fig. 1A–
D), from which it was evident that the untreated E. coli (CNTRL-
N) exhibited exponential growth up to 24 h and started decaying
aer that. The optical density (OD600) of E. coli with Pln0 and
Pln1 was found to follow the pattern similar to CNTRL-N with
lower OD implying inhibition of bacterial growth over the
duration of the experiment and Pln1 substantially inhibited E.
coli to a greater extent than Pln0 (Fig. 1A). The OD pattern of
Pln2 and Pln3 was highly suppressed compared to CNTRL-N
implying bactericidal activity. Pure Ag3PO4 initially followed
a similar turbidity pattern as that of Pln3 but experienced
a sudden rise in turbidity aer 48 h. This unperturbed incre-
ment of OD in presence of Ag3PO4 may be due to the degrada-
tion of Ag3PO4.53
In the case of S. aureus, the untreated solution (CNTRL-P)
exhibited exponential growth to 24 h and became saturated
for the rest of the experiment. Further observation revealed that
Pln1, Pln2 and Pln3 followed similar OD patterns as that of
CNTRL-P, but with suppressed intensity implying bacteriostatic
activity.16 Among them Pln1 caused lowest turbidity of S. aureusThis journal is © The Royal Society of Chemistry 2020solution among all samples indicating its highest antibacterial
propensity. In the case of Pln0, the antibacterial activity was
sustained for 7 days. Ag3PO4 initiated bacterial interactionsRSC Adv., 2020, 10, 11060–11073 | 11065
Fig. 2 (A and B) Biofilm inhibition efficiency against E. coli and S.
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View Article Onlinewith inhibitions as observed from its OD pattern (Fig. 1B), but
aer 48 h there was a gradual increase in the OD implying
strong repulsive interaction with S. aureus. The antibacterial
activity of polyindole composites over prolonged exposure was
particularly interesting. Fig. 1C and D explores the percentage
inhibition efficiency of composites for 7 days against both
bacteria. Pure Ag3PO4 exhibited 83.4 and 73.5% inhibition
efficiency against E. coli and S. aureus respectively aer 24 h and
this efficacy gradually diminished as time surpasses and attains
negligible value aer 7 days. Pln0 exhibited moderate antibac-
terial activity, e.g. 23.2 and 26.0% against E. coli and S. aureus
aer 24 h respectively and it was noteworthy that aer 5 days the
inhibition efficiency is 7.4 and 4.8% against E. coli and S.
aureus, respectively, i.e. long-term antibacterial activity. Pln1
displayed higher antibacterial activity (70.5, 76.5% and 20.8,
22.0% efficiency against E. coli and S. aureus aer 24 h and 5
days respectively) than Pln0. Pln2 inhibited the growth of E. coli
and S. aureus by 87.4 and 55.3% aer 24 h, respectively. It is
noteworthy that the highest antibacterial activity was achieved
by Pln2 against both bacteria aer 5 days (25.6 and 24.8%
against E. coli and S. aureus, respectively). Similar bacterial
growth inhibition pattern was observed for Pln3. By synthe-
sizing Ag3PO4/polyindole composites at 2 : 1 w/w ratio, we have
achieved two goals simultaneously in: superior antibacterial
activity and sustained bacterial inhibition for a prolonged time.
Long term interaction with S. aureus was more effective than for
E. coli (Fig. 1C and D). Aer 7 days exposure it was observed that
all composites exhibited higher antibacterial activity against S.
aureus than E. coli.aureus after 4 days exposure of pure Ag3PO4, Pln0 and Ag3PO4/pol-
yindole nanocomposites.Biolm inhibition
In nature, bacteria other than its planktonic forms sometimes
build up aggregated and stacked layers of surface-adherent
structured communities known as biolms, which sometimes
present resistance to bioactive molecules (particularly antibi-
otics). Several mechanisms were proposed for this resistance
against antibiotics, including primarily adhesion of bacteria to
living and non-living surfaces which resist in vivo any host
immune systems or biocides and undertake cellular processes
at relatively slower rates in order to be antibiotic resistant.71
Moreover, a biolm's exopolymeric matrix and bacterial dead
cells act as a barrier for the diffusion of antibiotics/drug mole-
cules thus protecting the live bacteria.72 Therefore the design
and development of novel biolm inhibitors is a societal grand
challenge. Ag3PO4/Pln composites and the constituent mate-
rials alone can be delivered to biolms formed by E. coli and S.
aureus as these biolms were frequently found in orthopaedic
implant devices.68
The anti-biolm activity of the materials wasmeasured using
a crystal violet assay based colorimetric detection protocol
(Fig. 2A and B) which in advance quanties the amount of
extracellular polymeric substances, generated by biolms and
indirectly monitors biolm biomasses.6,16,58 The respective
inhibition efficiency of these nanocomposites is calculated
according to the method suggested by Jaiswal et al.73 It is
noteworthy that the Ag3PO4/Pln nanocomposites inactivate the11066 | RSC Adv., 2020, 10, 11060–11073microbial biolms to various extents. The highest biolm
inhibition efficiency against E. coli was observed for Pln2, fol-
lowed by Pln1 and Pln3 (Fig. 2A). Similarly for S. aureus the
highest inhibition was notied for Pln3 followed by Pln2
(Fig. 2B) Such an observation was comparable with that of Ag
nanoparticles against S. epidermis (10–15%).71
Under the experimental conditions used, pure Ag3PO4 was
unsuccessful at inhibiting bacterial biolms which may be due
to its structural instability.53 Pln0 displayed long term antibac-
terial activity (Fig. 1C and D) but was unsuccessful in the
retardation of biolm formation (Fig. 2A and B). This can be
ascertained from physiological differences between planktonic
bacteria and their biolms.72 Therefore, simultaneous existence
of antibacterial and anti-biolm activity in Ag3PO4/Pln
composites could enable them being efficient wound healing
material especially for skin infection.48 Interestingly, Pln2
exhibited the highest antibacterial and biolm inhibition
against E. coli, suggesting that these two activities were related
with the electronic structure of Pln2 as well as its outcomes (e.g.
ROS yield). Anti-biolm activity is markedly less than the anti-
bacterial activity, which was in line with the literature that
materials with simultaneous antibacterial and anti-biolm
activity may not be efficient against mature biolms.73This journal is © The Royal Society of Chemistry 2020
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View Article OnlineAntibacterial mechanism
The difference in antibacterial potency demonstrated earlier
may be accounted for by the dissimilar cellular structures of S.
aureus and E. coli, but the varied inhibition efficiency among
composites indicated that parameters other than physiological
differences between bacteria might be important. The means by
which cellular damage by ROS74 and non-ROS include the
dissolution of cations,7 internalization of nanostructures,7 cell
membrane disintegration via protein leakage,75 membrane
permeability changes60 may explain the antibacterial activity of
the nanostructured materials. We examined ROS generation
from the nanostructures extracellularly and intracellularly.In vitro ROS generation
ROS generated by semiconducting nanomaterials outside the
cell are extracellular ROS. These free radicals are produced
either by light irradiation or in the dark which essentially
require two conditions: (1) the light energy should be greater or
equal to the band gap of the nanomaterial and (2) defect states
in nanomaterials which can facilitate electron transport.76 In
our present work we have carried out in vitro ROS generation
assays in dark environments, so defect-induced electron trans-
port is the accepted mechanism for ROS generation. Typically
three different ROS0 are generated in semiconducting nano-
materials, superoxide anion (O2c
), hydroxyl radical ($OH) and
singlet oxygen (1O2) as typically their generation involves
conduction band electrons and valence band holes of nano-
materials. From in vitro ROS generation studies, we could not
nd any correlation between ROS yield with long-term anti-
bacterial activity (Fig. S6†). Singlet oxygen can be formed due to
valence band edge energy EVB ¼ 2.66 eV (>EH of 1O2/O2 ¼ 1.88
eV) but there is no direct correlation between singlet oxygen
generation with the antibacterial and anticancer activities,
highlighting the need for further investigation. The different
ROS generation abilities of Ag3PO4, Pln0, Pln1, Pln2 and Pln3
are related with mismatched band structure between silver
phosphate and polyindole. Consequently, we employed an
intracellular ROS generation assay to study antibacterial activity
for long-term basis.Fig. 3 Intracellular H2O2 generation form (A) E. coli and (B) S. aureus
after treatment with Ag3PO4, Pln0, Pln1, Pln2 and Pln3 for 24, 48 h and
5, 7 days.Intracellular ROS detection
High intracellular ROS levels and resultant oxidative assault
have been highly cited as important factors for bacterial cell
death induced by nanomaterials (including metal oxides and
their polymer-based composites)20 but long term intracellular
ROS release and their impact on antibacterial activity of Ag3PO4/
Pln nanocomposites was not reported elsewhere. We have pre-
sented such long-term release of intracellular ROS induced by
Ag3PO4/Pln nanocomposites. During cellular metabolism, ROS
are produced as by-products of biochemical reactions, O2c
 is
the primary ROS that is produced aer O2 consumption, and
with the aid of dismutation reaction O2c
 is transformed into
H2O2 which is commonly known as intracellular ROS.9,20,77 The
ROS level is continuously being adjusted by endogenous anti-
oxidants77 but this ROS level might be increased by ROS0This journal is © The Royal Society of Chemistry 2020produced under different environmental conditions by the
nanomaterials.76,77 To investigate the long-term potential of
Ag3PO4/Pln nanocomposites to induce ROS generation in E. coli
and S. aureus, DCFH-DA staining microplate assays were
employed for 1–7 days. DCFH-DA is a cell permeable indicator
for ROS and non-uorescent dye until its acetate group is
eliminated by cellular esterases during oxidation processes
inside the cell. The intermediate reduced form of DCFH is
subject to subsequent oxidation by H2O2 to produce dichloro-
uorescein (DCF) which uoresces. Thus, the uorescent
intensity of DCF indirectly measures the amount of H2O2 inside
the cell. Fig. 3A and B depicts the intracellular H2O2 generation
from E. coli and S. aureus aer treatment with 1 mg mL1 of
nanocomposites for 1–7 days.
The intracellular ROS levels due to induction of nano-
composites was quite high but decayed over time. Pln2 induced
the highest intracellular ROS in E. coli; whereas Pln3 did in S.
aureus aer treatment for 24 h., bare Ag3PO4 and Pln0 were
incapable of inducing intracellular ROS levels in both bacteria
aer 24 h treatment. Aer 48 h of treatment, the nano-
composites (especially Pln2 and Pln1) induced high levels of
intracellular ROS level in E. coli and S. aureus respectively. One
noticeable nding was that the uorescence intensities of E. coliRSC Adv., 2020, 10, 11060–11073 | 11067
Fig. 4 FL intensity of PI in (A) E. coli and (B) S. aureus induced by
Ag3PO4, Pln0, Pln1, Pln2 and Pln3 for 24, 48 h and 5, 7 days.
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View Article Onlineitself were drastically lowered from its 24 h value, which implies
that the cells lack nutrients to grow and underwent degenera-
tive processes, which further obstructed the cell permeation of
DCFH-DA. Furthermore, the Ag3PO4/Pln nanocomposites
induced ROS generation, corroborating their effect on anti-
bacterial activity. The release of Ag+ ions from the Ag3PO4 in the
composite in the light exposure. As our investigation was
carried out in the dark, there is less possibility of release of Ag+
ions. Another observation was that although bare Ag3PO4 and
Pln0 did not induce higher ROS levels in E. coli and S. aureus,
their antibacterial activity (particularly aer 24 h treatment)
(Fig. 1C and D) require mechanistic studies of this antibacterial
activity in the future. Targeting bacterial membrane functions is
an emerging approach for inhibiting antibiotic resistant
bacterial infections.60 Unlike mammalian cell membrane,
bacterial cell membrane is formulated by several negatively
charged lipids e.g. cardiolipin, phosphatidylglycerol, lipopoly-
saccharides, lipoteichoic acid etc.60 The basic mechanisms
behind such membrane targeting include: binding the nega-
tively charged membrane protein by cationic membrane active
agents, and alteration of membrane permeability.60 In our case
the surface potentials of the Ag3PO4/Pln nanocomposites were11068 | RSC Adv., 2020, 10, 11060–11073anionic in nature so the binding force to membrane proteins
was likely to be negligible so the antibacterial activity may be the
outcome of membrane permeability alteration.
Membrane disintegrity measurement
In case of E. coli, high effect on cell permeabilization is observed
only for Pln0 indicating bactericidal effect accounted to
membrane disintegration (analogous to the literature).60 A
small effect on uorescence was observed for Pln1 and Pln3
which provoked membrane depolarization for their antibacte-
rial activity (Fig. 4). In the case of S. aureus, the membrane
disintegration pattern (PI uorescence) was also reproduced in
Pln0, Pln2 and Pln3 while that of Pln1 resembles Ag3PO4 indi-
cating sustainable membrane rupturing by Pln0 and its
composites with increased polymer proportion and at the same
time rapid degradation of Ag3PO4. Membrane permeabilization
was most effective for Pln2 followed by Pln3 and Ag3PO4.
Cytotoxicity assessment of Ag3PO4/Pln nanocomposite
Ag3PO4/Pln nanocomposites have potential antibacterial ability
in the dark by elevating levels of intracellular ROS. As ROS are
important for killing cancer cells,14,78,79 we have evaluated the
anticancer activity of the Ag3PO4/Pln nanocomposites. The data
presented in Fig. 5 demonstrates the activity of Ag3PO4/Pln
nanocomposites in MCF-7 breast cancer cells treatment. The
impact of Ag3PO4/Pln nanocomposites on the mortality of MCF-
7 cells was assessed using the MTT assay. The cytotoxic effect of
the nanocomposites on peripheral blood mononuclear cells
(PBMCs) is depicted in Fig. 5A.
The results of the time and dose dependent study of the
cytotoxic effect of the nanocomposites on MCF-7 cells is pre-
sented in Fig. 5B–F. From Fig. 5A it is observed that the nano-
composites became nontoxic to PBMC cells within 20–50 mg
mL1, beyond which the composites showed toxicity towards
the cell lines although the overall performance was still lower
than cisplatin that exhibits 25% cell viability at 16.66 mg mL1
aer 24 h treatment. In the case of the MCF-7 cell line, cisplatin
at this concentration showed 48 and 58% cell viability aer 24
and 48 h treatment, respectively. To achieve anticancer activity
with minimal damage of normal cells, Ag3PO4/Pln nano-
composites are under development. Due to the benign effect of
Pln0, Ag3PO4 and Pln1 on PBMC cell lines; these materials have
long-term potential for cancer treatment. The time dependent
study of MCF-7 cells aer treatment with Ag3PO4 showed 30%
cell viability for 24 h and 40% for 48 h, if treated with 1mgmL1
but if we conned the treatment in the range of 20–50 mg mL1,
bare Ag3PO4 exhibits negligible anticancer activity. Similarly,
Pln0 also exhibited weak anticancer property over the entire
concentration range. On the contrary Pln1 exhibits superior
anticancer activity as compared to cisplatin, which is observed
from 50–1000 mgmL1. It showed the highest anticancer activity
with 24 and 26% cell viability aer 24 and 48 h incubation if
treated with 1 mg mL1. Even at lower concentration (20 mg
mL1), Pln1 exhibited 59 and 54% cell viability aer 24 and 48 h
treatment. This result was comparable to that of uorescein
isothiocyanate (FITC)/ZnO nanocomposites as observed byThis journal is © The Royal Society of Chemistry 2020
Fig. 5 (A) Cytotoxicity of Ag3PO4/Pln nanocomposite against PBMC cell after 24 h treatment, (B–F) cytotoxicity of Ag3PO4/Pln nanocomposite
against breast cancer cell MCF-7 after 24 and 48 h treatment for comparative assessment.
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
M
ar
ch
 2
02
0.
 D
ow
nl
oa
de
d 
on
 4
/2
8/
20
20
 4
:0
1:
49
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineGupta et al.14 This behaviour suggests potential long-term
anticancer activity of Pln1. In the case of Pln2 and Pln3, excel-
lent anticancer activity with minimal cell viability was observed,
but due to considerable toxicity towards the PBMC cell, they are
not employed in anticancer treatments as an alternative of
cisplatin. Therefore, our cytotoxicity assessment demonstrates
that these Ag3PO4/Pln nanocomposite can potentially inhibit
cancer cell proliferation in vitro and may prove to be an alter-
native to conventional chemotherapeutic drugs.
In vitro anti-inammation study
During bacterial infection macrophages are activated by lipo-
polysaccharides (LPS) which are components of the cell walls of
Gram negative bacteria, and there is subsequent secretion of
leukotrienes and pro-inammatory cytokines like Tumor
Necrosis Factor a (TNF-a) and Interleukin-1b (IL-1b).38 Macro-
phages exposed to stimulants such as LPS or PMA experience
respiration bursts which are further accompanied by ROS
production resulting destruction of adjacent cells and tissues byThis journal is © The Royal Society of Chemistry 2020the inammation mechanism.41 Therefore there is a need for
the development of anti-inammatory drugs to heal LPS
induced macrophages. We used THP-1 derived macrophages as
an in vitro model to investigate anti-inammatory activity. The
macrophages were initially treated by LPS and IFN-g to under-
stand the anti-oxidant nature of Ag3PO4/Pln nanocomposites
(Fig. 6 and S7†). There was a dramatic change in morphology of
the cells aer incubation with LPS and IFN-g (Fig. 6B). The cells
were round in shape and bigger before the treatment (Fig. 6A),
but aer incubation with LPS and IFN-g the cells become
smaller and atter with elongated shapes [Fig. 6B]. Fig. 6C–G
illustrated the particle internalization into the stimulated
macrophages aer seeding with 50 mg mL1 of Ag3PO4/Pln
nanocomposites for 3 days. The data presented in Fig. 6D
depicts the macrophages treated with LPS/IFN-g and subse-
quent seeding with the nanocomposites revealed that only Pln0
was able to penetrate into the cells (Fig. 6D).
NO is a powerful ROS generator in macrophages in the
presence of stimulants, and thus the NO secretion from theRSC Adv., 2020, 10, 11060–11073 | 11069
Fig. 7 NO secretion from THP-1 derived macrophage with LPS and
IFN-g stimulation and incubation with the various nanoparticles. (A) In
the absence of light, (B) in the presence of light. All data are presented
as mean  SD (n ¼ 4).
Fig. 6 Morphology of THP-1 derived macrophages after incubating
with PIn or Ag3PO4 particles for 3 days. THP-1 cells have been induced
by PMA, then stimulated by LPS (1 mgmL1) and IFN-g (20 ngmL1). (A)
THP-1 derived macrophage by PMA but without stimulation by LPS
and IFN-g. (B) THP-1 derived macrophage with LPS and IFN-g stim-
ulation; (C) THP-1 derivedmacrophage with LPS and IFN-g stimulation
and incubating with Ag3PO4; (D) THP-1 derived macrophage with LPS
11070 | RSC Adv., 2020, 10, 11060–11073
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View Article Onlinemacrophages aer seeding with the nanocomposites would
help to predict the anti-inammatory effect of the nano-
composites. Fig. 7A depicts the NO secretion from LPS treated
macrophages along with the nanocomposites in absence of
light. It is dramatically lowered aer seeding with Pln2 (40%),
Pln0 (50%). As compared to other components of the nano-
composites, bare Ag3PO4 did inhibit NO secretion by 60% effi-
cacy. To validate this observation the same investigation was
performed in the presence of light (Fig. 7B). In the latter case
only Pln0 showed signicant anti-inammatory activity as
compared to the other materials. This was due to rapid gener-
ation of ROS from these materials. DPPH is a stable free radical,
which is used to assess the free radical scavenging capacity by
the particles. As shown in Fig. 8, Ag3PO4 had the strongest free
radical scavenging capacity, to 80% inhibition, whilst PIn1 can
achieve nearly 70% inhibition. From conduction band edge
potential of bare Ag3PO4 (ECB ¼ 0.27 eV) it was clear that bare
Ag3PO4 cannot produce O2c
 (EH of O2c
/O2 ¼ 0.2 eV) which
promotes NO to yield different reactive nitrogen species. Thus,
it can inhibit NO production in THP-I derived cells.and IFN-g stimulation and incubating with Pln0; (E) THP-1 derived
macrophage with LPS and IFN-g stimulation and incubating with Pln1;
(F) THP-1 derived macrophage with LPS and IFN-g stimulation and
incubating with Pln2; (G) THP-1 derived macrophage with LPS and
IFN-g stimulation and incubating with Pln3. All the nanocomposites
concentration in (C–G) groups were counted at a concentration of 50
particles per cell.
This journal is © The Royal Society of Chemistry 2020
Fig. 8 Anti-oxidation measurement by DPPH radical scavenging
capacity for the various particles. Data are presented as mean  SD (n
¼ 4).
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View Article OnlineConclusions
The Ag3PO4/Pln nanocomposites presented here show long-
term antibacterial activity in the dark. Specically the
composites with Pln content of 50% of Ag3PO4 show superior
antibacterial activity with long-term durability. This particular
composition also inhibited bacterial biolms efficiently. Inter-
estingly pure polyindole also exhibited antibacterial activity for
a longer time period than that of pure Ag3PO4. The underlying
factor for such long-term antibacterial activity is accounted for
by intracellular ROS production from the composites. The
composites with Pln content of 50% of Ag3PO4 generated the
highest amount of intracellular ROS for a prolonged time
period. Pure polyindole's antibacterial activity as well as the
composite with the highest content of polyindole promoted
membrane disintegration, which is the prime cause of their
antibacterial activity. Additionally the composites exhibited
anticancer activity with low toxicity towards other cells. THP-1
derived macrophages can be protected from LPS stimulation
by composites with Pln contents of 25% of Ag3PO4 in the dark.
The Ag3PO4/Pln nanocomposites are efficient antibacterial
agents for long durations with a simultaneous anti-
inammatory response. In addition, the nanocomposites have
potential for anticancer therapy. Clearly, the promise of these
materials will need signicantly more detailed studies, e.g.
physicochemical (for example ESR),80–83 in vitro,84 in silico,85–87 in
vivo (in pre-clinical models, e.g. small mammals),88 and there-
aer clinical trials prior to translation to the clinic; such
nanocomposites therefore have a variety of potential technical
and medical applications.89Conflicts of interest
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